Unaudited Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended		9 Months Ended		12 Months Ended
	Sep. 30, 2020	Sep. 30, 2019	Sep. 30, 2020	Sep. 30, 2019	Dec. 31, 2019
Cash flows from operating activities
Net loss	$ (17,701)	$ (6,376)	$ (39,255)	$ (20,045)
Adjustments to reconcile net loss to net cash used in operating activities:
(Gain)/loss on recognition of contingent consideration payable			(101)	2
Other (income)/expense	(416)	75	(296)	231
Unrealized foreign exchange gain			(40)	342
Depreciation of operating right-of-use assets			252	283
Depreciation			267	268
Amortization of intangible assets			827	791	$ 1,000
Loss on disposal of assets			0	33
Impairment of intangible assets	859	0	859	0
Stock-based compensation			1,188	848
Deferred income taxes			99	(120)
Change in operating assets and liabilities:
Accounts receivable			(3,480)	2,750
Prepaid expenses			1,431	2,725
Other current assets			(294)	641
Research and development tax credit receivable			(3,497)	1,806
Deferred income			5,286	(2,608)
Accounts payable			(1,849)	(521)
Accrued liabilities			(1,196)	(244)
Contingent consideration paid			0	(701)
Lease liabilities			(341)	(342)
Net cash used in operating activities			(40,140)	(13,861)
Investing activities
Purchase of property, plant and equipment			(371)	(247)
Purchase of intangible assets			0	(111)
Net cash used in investing activities			(371)	(358)
Financing activities
Proceeds from issue of share capital			0	25,081
Transaction costs on share capital issued			0	(579)
Proceeds from exercise of share options			3	2
Net cash provided by financing activities			3	24,504
(Decrease) / increase in cash and cash equivalents			(40,508)	10,285
Effect of exchange rates on cash and cash equivalents			(2,064)	(787)
Cash and cash equivalents at beginning of the year			63,842	12,138	12,138
Cash and cash equivalents at end of the year	$ 21,270	$ 21,636	$ 21,270	$ 21,636	$ 63,842